Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Horizon Therapeutics Public Ltd Co (HZNP)
since 2014 are shown in Table 1 and Table 2.
Table 1 shows the monthly insider trading data of Horizon Therapeutics Public Ltd Co.
Table 2 shows the detailed insider transactions.
This company's CIK number is 1492426.
Total stock buying since 2014: $516,269.
Total stock sales since 2014: $517,726,907.
Total stock option exercises since 2014: $36,014,329.
Table 3. Detailed insider trading at Horizon Therapeutics Public Ltd Co (HZNP)
Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
2023-10-02 | Santini Gino (Director) | Option Ex | 23,092 | 15.23 | 351,691 |
2023-09-29 | Shannon James Samuel (Director) | Option Ex | 11,850 | 12.19 | 144,451 |
2023-09-29 | Watkins Thomas (Director) | Option Ex | 81,323 | 14.04 | 1,141,774 |
2023-09-28 | Grey Michael G (Director) | Option Ex | 20,000 | 15.96 | 319,200 |
2023-09-26 | Himawan Jeff (Director) | Option Ex | 32,161 | 13.87 | 446,073 |
2023-09-22 | Santini Gino (Director) | Option Ex | 20,000 | 15.96 | 319,200 |
2023-04-28 | Witz Pascale (Director) | Option Ex | 3,913 | .00 | 0 |
2023-04-28 | Daniel William F (Director) | Option Ex | 3,913 | .00 | 0 |
2023-04-28 | Shannon James Samuel (Director) | Option Ex | 3,913 | .00 | 0 |
2023-04-28 | Mahony Susan (Director) | Option Ex | 3,913 | .00 | 0 |
2023-04-28 | Himawan Jeff (Director) | Option Ex | 3,913 | .00 | 0 |
2023-04-28 | Watkins Thomas (Director) | Option Ex | 3,913 | .00 | 0 |
2023-04-28 | Santini Gino (Director) | Option Ex | 3,913 | .00 | 0 |
2023-04-28 | Grey Michael G (Director) | Option Ex | 3,913 | .00 | 0 |
2023-03-02 | Desjardin Michael A. (EVP, Technical Operations) | Option Ex | 4,372 | 16.06 | 70,214 |
2023-03-01 | Clayton Sean M. (EVP, General Counsel) | Option Ex | 14,129 | .00 | 0 |
2023-01-13 | Cox Aaron (EVP, Chief Financial Officer) | Sale | 36,148 | 113.17 | 4,090,833 |
2023-01-11 | Sherman Jeffrey W (EVP and Chief Medical Officer) | Sale | 3,368 | 113.10 | 380,920 |
2023-01-10 | Sherman Jeffrey W (EVP and Chief Medical Officer) | Sale | 3,368 | 113.05 | 380,752 |
2022-12-13 | Pasternak Andy (EVP, Chief Strategy Officer) | Sale | 30,169 | 112.60 | 3,397,119 |
2022-12-13 | Pasternak Andy (EVP, Chief Strategy Officer) | Option Ex | 23,251 | 29.52 | 686,369 |
2022-12-12 | Sherman Jeffrey W (EVP and Chief Medical Officer) | Sale | 28,352 | 111.44 | 3,159,688 |
2022-11-01 | Pasternak Andy (EVP and Chief Business Officer) | Option Ex | 12,421 | .00 | 0 |
2022-08-04 | Clayton Sean M. (EVP, General Counsel) | Buy | 745 | 66.67 | 49,669 |
2022-07-29 | Pasternak Andy (EVP and Chief Business Officer) | Sale | 4,850 | 82.94 | 402,283 |
2022-07-20 | Thompson Elizabeth H.z. (EVP, Research & Development) | Sale | 5,917 | 85.00 | 502,945 |
2022-07-19 | Thompson Elizabeth H.z. (EVP, Research & Development) | Sale | 90 | 85.03 | 7,652 |
2022-07-07 | Thompson Elizabeth H.z. (EVP, Research & Development) | Sale | 82 | 85.01 | 6,970 |
2022-06-10 | Pasternak Andy (EVP and Chief Business Officer) | Sale | 762 | 85.36 | 65,044 |
2022-06-03 | Walbert Timothy P (Chairman, President and CEO) | Sale | 25,000 | 92.41 | 2,310,250 |
2022-06-03 | Walbert Timothy P (Chairman, President and CEO) | Option Ex | 25,000 | 22.14 | 553,500 |
2022-05-31 | Walbert Timothy P (Chairman, President and CEO) | Sale | 25,000 | 93.24 | 2,330,925 |
2022-05-20 | Walbert Timothy P (Chairman, President and CEO) | Sale | 25,000 | 90.00 | 2,250,000 |
2022-05-20 | Walbert Timothy P (Chairman, President and CEO) | Option Ex | 25,000 | 22.14 | 553,500 |
2022-05-11 | Walbert Timothy P (Chairman, President and CEO) | Sale | 17,600 | 90.00 | 1,584,000 |
2022-05-11 | Walbert Timothy P (Chairman, President and CEO) | Option Ex | 17,600 | 22.14 | 389,664 |
2022-05-06 | Walbert Timothy P (Chairman, President and CEO) | Sale | 7,400 | 90.72 | 671,328 |
2022-05-06 | Walbert Timothy P (Chairman, President and CEO) | Option Ex | 7,400 | 22.14 | 163,836 |
2022-05-02 | Walbert Timothy P (Chairman, President and CEO) | Sale | 25,000 | 96.48 | 2,411,925 |
2022-04-29 | Witz Pascale (Director) | Option Ex | 4,223 | .00 | 0 |
2022-04-29 | Daniel William F (Director) | Option Ex | 4,223 | .00 | 0 |
2022-04-29 | Shannon James Samuel (Director) | Option Ex | 4,223 | .00 | 0 |
2022-04-29 | Mahony Susan (Director) | Option Ex | 4,223 | .00 | 0 |
2022-04-29 | Himawan Jeff (Director) | Option Ex | 4,223 | .00 | 0 |
2022-04-29 | Watkins Thomas (Director) | Option Ex | 4,223 | .00 | 0 |
2022-04-29 | Santini Gino (Director) | Option Ex | 4,223 | .00 | 0 |
2022-04-29 | Grey Michael G (Director) | Option Ex | 4,223 | .00 | 0 |
2022-04-22 | Walbert Timothy P (Chairman, President and CEO) | Sale | 25,000 | 107.61 | 2,690,325 |
2022-04-22 | Walbert Timothy P (Chairman, President and CEO) | Option Ex | 25,000 | 22.14 | 553,500 |
2022-04-20 | Hoelscher Paul W. (EVP, CFO) | Sale | 50,000 | 114.77 | 5,738,250 |
2022-04-20 | Hoelscher Paul W. (EVP, CFO) | Option Ex | 50,000 | 22.14 | 1,107,000 |
2022-04-18 | Thompson Elizabeth H.z. (EVP, Research & Development) | Sale | 8,098 | 115.64 | 936,452 |
2022-04-12 | Desjardin Michael A. (EVP, Technical Operations) | Sale | 20,214 | 113.08 | 2,285,698 |
2022-04-08 | Walbert Timothy P (Chairman, President and CEO) | Sale | 25,000 | 112.21 | 2,805,250 |
2022-04-08 | Walbert Timothy P (Chairman, President and CEO) | Option Ex | 25,000 | 22.14 | 553,500 |
2022-04-06 | Hoelscher Paul W. (EVP, CFO) | Sale | 307,045 | 110.01 | 33,778,020 |
2022-04-06 | Hoelscher Paul W. (EVP, CFO) | Option Ex | 215,335 | 19.05 | 4,102,131 |
2022-04-06 | Sherman Jeffrey W (EVP and Chief Medical Officer) | Sale | 42,009 | 110.02 | 4,621,872 |
2022-03-30 | Walbert Timothy P (Chairman, President and CEO) | Sale | 50,000 | 105.06 | 5,253,250 |
2022-03-25 | Hoelscher Paul W. (EVP, CFO) | Sale | 663 | 110.00 | 72,930 |
2022-03-25 | Walbert Timothy P (Chairman, President and CEO) | Sale | 25,000 | 109.37 | 2,734,350 |
2022-03-25 | Walbert Timothy P (Chairman, President and CEO) | Option Ex | 25,000 | 22.14 | 553,500 |
2022-03-24 | Hoelscher Paul W. (EVP, CFO) | Sale | 1,481 | 110.00 | 162,910 |
2022-03-23 | Hoelscher Paul W. (EVP, CFO) | Sale | 37,789 | 110.01 | 4,157,054 |
2022-03-23 | Hoelscher Paul W. (EVP, CFO) | Option Ex | 26,090 | 15.96 | 416,396 |
2022-03-18 | Sherman Jeffrey W (EVP and Chief Medical Officer) | Option Ex | 8,531 | 22.14 | 188,876 |
2022-03-11 | Walbert Timothy P (Chairman, President and CEO) | Sale | 25,000 | 101.08 | 2,526,875 |
2022-03-11 | Walbert Timothy P (Chairman, President and CEO) | Option Ex | 25,000 | 22.14 | 553,500 |
2022-03-02 | Desjardin Michael A. (EVP, Technical Operations) | Sale | 35,000 | 97.23 | 3,403,225 |
2022-02-18 | Pasternak Andy (EVP and Chief Business Officer) | Sale | 1,313 | 94.82 | 124,498 |
2022-02-01 | Walbert Timothy P (Chairman, President and CEO) | Option Ex | 9,087 | .00 | 0 |
2022-01-31 | Walbert Timothy P (Chairman, President and CEO) | Sale | 100,000 | 91.77 | 9,177,000 |
2022-01-28 | Walbert Timothy P (Chairman, President and CEO) | Sale | 25,000 | 90.00 | 2,250,000 |
2022-01-28 | Walbert Timothy P (Chairman, President and CEO) | Option Ex | 25,000 | 22.14 | 553,500 |
2022-01-21 | Hoelscher Paul W. (EVP, CFO) | Option Ex | 5,558 | .00 | 0 |
2022-01-21 | Desjardin Michael A. (EVP, Technical Operations) | Option Ex | 3,679 | .00 | 0 |
2022-01-21 | Walbert Timothy P (Chairman, President and CEO) | Option Ex | 20,336 | .00 | 0 |
2022-01-21 | Sherman Jeffrey W (EVP and Chief Medical Officer) | Option Ex | 5,354 | .00 | 0 |
2022-01-14 | Walbert Timothy P (Chairman, President and CEO) | Sale | 25,000 | 90.02 | 2,250,425 |
2022-01-14 | Walbert Timothy P (Chairman, President and CEO) | Option Ex | 25,000 | 22.14 | 553,500 |
2022-01-06 | Pasternak Andy (EVP and Chief Business Officer) | Sale | 7,987 | 98.93 | 790,137 |
2022-01-05 | Thompson Elizabeth H.z. (EVP, Research & Development) | Option Ex | 13,999 | .00 | 0 |
2022-01-05 | Pasternak Andy (EVP and Chief Business Officer) | Option Ex | 48,839 | .00 | 0 |
2022-01-05 | Moze Barry (EVP, Chief Admin. Officer) | Option Ex | 64,959 | .00 | 0 |
2022-01-05 | Hoelscher Paul W. (EVP, CFO) | Option Ex | 66,822 | .00 | 0 |
2022-01-05 | Desjardin Michael A. (EVP, Technical Operations) | Option Ex | 53,734 | .00 | 0 |
2022-01-05 | Mchugh Miles W (Sr VP & Princ. Acctg Officer) | Option Ex | 18,289 | .00 | 0 |
2022-01-05 | Walbert Timothy P (Chairman, President and CEO) | Option Ex | 249,793 | .00 | 0 |
2022-01-05 | Sherman Jeffrey W (EVP and Chief Medical Officer) | Option Ex | 52,570 | .00 | 0 |
2021-12-31 | Walbert Timothy P (Chairman, President and CEO) | Sale | 75,000 | 108.28 | 8,121,375 |
2021-12-31 | Walbert Timothy P (Chairman, President and CEO) | Option Ex | 25,000 | 22.14 | 553,500 |
2021-12-28 | Hoelscher Paul W. (EVP, CFO) | Sale | 8,575 | 110.00 | 943,250 |
2021-12-28 | Hoelscher Paul W. (EVP, CFO) | Option Ex | 8,575 | 15.96 | 136,857 |
2021-12-07 | Pasternak Andy (EVP and Chief Business Officer) | Sale | 1,525 | 100.00 | 152,500 |
2021-12-01 | Mchugh Miles W (Sr VP & Princ. Acctg Officer) | Sale | 79,484 | 106.62 | 8,474,584 |
2021-12-01 | Mchugh Miles W (Sr VP & Princ. Acctg Officer) | Option Ex | 79,484 | 22.14 | 1,759,775 |
2021-11-30 | Walbert Timothy P (Chairman, President and CEO) | Sale | 50,000 | 102.55 | 5,127,350 |
2021-11-04 | Pasternak Andy (EVP and Chief Business Officer) | Sale | 30,168 | 113.02 | 3,409,436 |
2021-11-04 | Pasternak Andy (EVP and Chief Business Officer) | Option Ex | 23,251 | 29.52 | 686,369 |
2021-11-04 | Moze Barry (EVP, Chief Admin. Officer) | Sale | 75,743 | 112.99 | 8,558,428 |
2021-11-04 | Moze Barry (EVP, Chief Admin. Officer) | Option Ex | 75,743 | 16.14 | 1,222,719 |
2021-11-01 | Pasternak Andy (EVP and Chief Business Officer) | Option Ex | 12,421 | .00 | 0 |
2021-11-01 | Walbert Timothy P (Chairman, President and CEO) | Sale | 25,000 | 118.81 | 2,970,125 |
2021-10-27 | Sherman Jeffrey W (EVP and Chief Medical Officer) | Option Ex | 10,729 | 7.61 | 81,647 |
2021-09-30 | Walbert Timothy P (Chairman, President and CEO) | Sale | 50,000 | 110.92 | 5,546,150 |
2021-09-21 | Sherman Jeffrey W (EVP and Chief Medical Officer) | Sale | 46,271 | 110.00 | 5,089,810 |
2021-09-21 | Sherman Jeffrey W (EVP and Chief Medical Officer) | Option Ex | 46,271 | 7.61 | 352,122 |
2021-09-17 | Beeler Brian K (EVP, General Counsel) | Sale | 28,143 | 107.91 | 3,036,911 |
2021-09-09 | Pasternak Andy (EVP and Chief Business Officer) | Sale | 23,250 | 108.05 | 2,512,046 |
2021-09-09 | Pasternak Andy (EVP and Chief Business Officer) | Option Ex | 23,250 | 29.52 | 686,340 |
2021-08-27 | Walbert Timothy P (Chairman, President and CEO) | Option Ex | 7,435 | 22.14 | 164,610 |
2021-08-16 | Beeler Brian K (EVP, General Counsel) | Sale | 74,898 | 106.00 | 7,939,188 |
2021-08-16 | Beeler Brian K (EVP, General Counsel) | Option Ex | 65,857 | 22.14 | 1,458,073 |
2021-08-05 | Thompson Elizabeth H.z. (EVP, Research & Development) | Sale | 7,542 | 106.34 | 802,023 |
2021-07-30 | Walbert Timothy P (Chairman, President and CEO) | Sale | 25,000 | 102.11 | 2,552,750 |
2021-07-22 | Grey Michael G (Director) | Sale | 5,000 | 100.03 | 500,125 |
2021-07-22 | Grey Michael G (Director) | Option Ex | 5,000 | 2.37 | 11,850 |
2021-07-08 | Moze Barry (EVP, Chief Admin. Officer) | Sale | 35,076 | 92.37 | 3,239,970 |
2021-07-01 | Thompson Elizabeth H.z. (EVP, Research & Development) | Option Ex | 12,077 | .00 | 0 |
2021-07-01 | Sherman Jeffrey W (EVP and Chief Medical Officer) | Sale | 60,076 | 95.00 | 5,707,280 |
2021-06-30 | Walbert Timothy P (Chairman, President and CEO) | Sale | 25,000 | 94.29 | 2,357,250 |
2021-06-10 | Mchugh Miles W (Sr VP & Princ. Acctg Officer) | Option Ex | 3,334 | .00 | 0 |
2021-06-01 | Walbert Timothy P (Chairman, President and CEO) | Sale | 25,000 | 91.61 | 2,290,125 |
2021-05-11 | Kent Jeff (See remarks) | Option Ex | 12,592 | 22.14 | 278,786 |
2021-05-10 | Daniel William F (Director) | Sale | 20,000 | 86.78 | 1,735,700 |
2021-05-10 | Daniel William F (Director) | Option Ex | 20,000 | 12.70 | 254,000 |
2021-04-30 | Witz Pascale (Director) | Option Ex | 11,098 | .00 | 0 |
2021-04-30 | Mahony Susan (Director) | Option Ex | 11,098 | .00 | 0 |
2021-04-30 | Walbert Timothy P (Chairman, President and CEO) | Sale | 25,000 | 94.64 | 2,366,125 |
2021-04-30 | Himawan Jeff (Director) | Option Ex | 11,098 | .00 | 0 |
2021-04-30 | Watkins Thomas (Director) | Option Ex | 11,098 | .00 | 0 |
2021-04-30 | Grey Michael G (Director) | Option Ex | 11,098 | .00 | 0 |
2021-04-12 | Moze Barry (EVP, Chief Admin. Officer) | Sale | 65,613 | 89.53 | 5,874,397 |
2021-04-05 | Camardo Daniel A. (EVP and President, U.S.) | Option Ex | 18,281 | 19.31 | 353,060 |
2021-04-01 | Curtis Geoffrey M. (EVP, Corporate Affairs, CCO) | Sale | 70,739 | 93.51 | 6,615,086 |
2021-04-01 | Curtis Geoffrey M. (EVP, Corporate Affairs, CCO) | Option Ex | 37,000 | 28.32 | 1,048,025 |
2021-03-31 | Beeler Brian K (EVP, General Counsel) | Sale | 26,844 | 90.12 | 2,419,181 |
2021-03-30 | Camardo Daniel A. (EVP and President, U.S.) | Sale | 12,900 | 85.33 | 1,100,692 |
2021-03-01 | Shannon James Samuel (Director) | Sale | 7,232 | 91.30 | 660,259 |
2021-03-01 | Shannon James Samuel (Director) | Option Ex | 7,232 | 12.19 | 88,158 |
2021-03-01 | Walbert Timothy P (Chairman, President and CEO) | Sale | 26,975 | 91.63 | 2,471,800 |
2021-03-01 | Santini Gino (Director) | Sale | 12,000 | 91.47 | 1,097,604 |
2021-02-26 | Desjardin Michael A. (EVP, Technical Operations) | Sale | 1,099 | 91.83 | 100,921 |
2021-02-24 | Desjardin Michael A. (EVP, Technical Operations) | Sale | 15,944 | 91.10 | 1,452,498 |
2021-02-22 | Konstantinovsky Irina (EVP, Chief Human Resources Officer) | Sale | 5,698 | 87.80 | 500,295 |
2021-02-22 | Karnani Vikram (EVP & President, International) | Sale | 8,358 | 87.77 | 733,556 |
2021-02-21 | Camardo Daniel A. (EVP and President, U.S.) | Option Ex | 1,300 | .00 | 0 |
2021-02-21 | Desjardin Michael A. (EVP, Technical Operations) | Option Ex | 2,182 | .00 | 0 |
2021-02-11 | Desjardin Michael A. (EVP, Technical Operations) | Sale | 10,786 | 90.00 | 970,740 |
2021-02-02 | Desjardin Michael A. (EVP, Technical Operations) | Sale | 4,530 | 85.00 | 385,050 |
Insider trading activities including stock purchases, stock sales, and option exercises
of HZNP listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of Horizon Therapeutics Public Ltd Co (symbol HZNP,
CIK number 1492426) see
the Securities and Exchange Commission (SEC) website.